Article:ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures. (5913873)

From ScienceSource
Jump to: navigation, search

This page is the ScienceSource HTML version of the scholarly article described at https://www.wikidata.org/wiki/Q52569175. Its title is ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures. and the publication date was 2018-04-23. The initial author is Jia Wei.

Fuller metadata can be found in the Wikidata link, which lists all authors, and may have detailed items for some or all of them. There is further information on the article in the footer below. This page is a reference version, and is protected against editing.



Converted JATS paper:

Journal Information

Title: BMC Endocrine Disorders

ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures

  • Jia Wei
  • Sheyu Li
  • Qilin Liu
  • Yuchun Zhu
  • Nianwei Wu
  • Ying Tang
  • Qianrui Li
  • Kaiyun Ren
  • Qianying Zhang
  • Yerong Yu
  • Zhenmei An
  • Jing Chen
  • Jianwei Li

Publication date (epub): 4/2018

Publication date (pmc-release): 4/2018

Publication date (collection): /2018

Abstract

Background

Adrenocorticotropic hormone (ACTH)-independent Cushing’s syndrome (CS) with bilateral cortisol-secreting adenomas has been rarely reported in the literatures. Precise recognition and management of this disorder constitute a challenge to clinicians due to the difficulty of exact location of the functional lesions.

Case presentation

We herein report a new case of a Chinese female patient with a complaint of exertional dyspnea for over 10 years. ACTH-independent CS was diagnosed based on undetectable ACTH and unsuppressed cortisol levels by dexamethasone. Computed tomography (CT) scan indicated bilateral adrenal masses, and adrenal venous sampling (AVS) adjusted by plasma aldosterone revealed hypersecretion of cortisol from both adrenal glands. Bilateral cortisol-secreting adrenal adenomas were suspected and confirmed by the postoperative pathology in subsequent two-step bilateral laparoscopic adrenalectomy. The symptoms and signs of CS relieved after surgery with continuous glucocorticoid replacement.

Conclusions

AVS adjusted by plasma aldosterone could be a useful technique in diagnosing ACTH-independent CS with bilateral adrenal adenomas prior to surgery. And the aldosterone ratio could be used to confirm the success of adrenal vein cannulation in this situation.

Paper

Background

Cushing’s syndrome (CS), which results from prolonged excessive cortisol secretion, is a collection of complicated symptoms and associated with significant morbidity and mortality [[1], [2]]. Endogenous CS includes ACTH-dependent and ACTH-independent etiologies, the latter accounts for 15~ 20% of the cases and is usually induced by unilateral adrenal adenomas or adrenal carcinomas accompanied by autonomous adrenal cortisol secretion [[1]]. ACTH-independent CS is occasionally caused by bilateral adrenocortical lesions, including unilateral functional adenoma with a contralateral non-functional mass, bilateral ACTH-independent macronodular adrenal hyperplasia (AIMAH), bilateral primary pigmented nodular adrenocortical disease (PPNAD), and an extremely rare entity, bilateral adrenocortical tumors [[3]]. Determining the nature and function of bilateral adrenal masses is always a challenge in clinical practice [[4], [5]]. We herein report a new case of a Chinese female patient with ACTH-independent Cushing’s syndrome due to bilateral cortisol-secreting adenomas, which was diagnosed through adrenal venous sampling (AVS) adjusted by plasma aldosterone and subsequently confirmed by postoperative pathology. In addition, similar cases in the literatures were briefly summarized for discussion.

Case presentation

A 55-year-old Chinese female was admitted to our hospital complaining of exertional dyspnea for more than 10 years. She had been developing truncal obesity and facial rounding over the past 2 years, without evidence of acne, hirsutism or wide purple striae. The patient had a family history of hypertension and was diagnosed with hypertension 10 years prior to admission, and she had been using irbesartan, metoprolol and nifedipine XR since then. She was also diagnosed with hyperlipidemia and prescribed with statins for 5 years. The patient reported no history of alcohol or drug abuse, in particular, no history of steroid use.

Physical examination on admission showed elevated blood pressure (164/104 mmHg) and normal heart rate (74 beats per minute). The patient’s height, body weight and waist circumference were 156 cm, 51 kg and 88 cm, respectively, with a body mass index (BMI) of 20.96 kg/m2. She had a plethoric moon-shaped face, centripetal obesity, buffalo hump, accompanied by ecchymosis and slight edema at both lower limbs. Neurological examination was unremarkable except for slight muscle weakness of the lower-extremities.

Routine laboratory examinations showed normal complete blood cell count and hepatorenal parameters, whereas the level of serum triglyceride was slightly elevated. The fasting plasma glucose level was 7.33 mmol/L, and glycosylated hemoglobin (HbA1c) was 6.6% (Table 1). Endocrinological examinations showed that circadian rhythm of cortisol disappeared, and the level of ACTH was less than 1.00 ng/L (Table 2). Twenty-four-hour urine free cortisol (24 h UFC) elevated to 634.8μg/24 h (reference range: 20.26-127.55μg/24 h). The next morning (8 a.m.) serum cortisol level after an overnight 1 mg dexamethasone suppression test (DMST) was 787.5 nmol/L, indicated lack of normal suppression (Table 2). The diagnosis of ACTH-independent Cushing’s syndrome was therefore established.Table 1

Laboratory characteristics at the first admission and 1 year after bilateral adrenalectomy

First admission One year after operation Reference values
WBC (109/L) 8.44 8.75 3.5- 9.5
Hb (g/L) 127 124 115- 150
Plt (109/L) 195 262 100- 300
Glu (mmol/L) 7.33 4.77 3.9- 5.9
ALT (IU/L) 30 23 <  40
AST (IU/L) 35 27 <  35
Cre (umol/L) 52.0 48.0 37.0- 110.0
BUN (mmol/L) 6.05 4.60 3.13- 8.17
LDL-c (mmol/L) 3.29 1.58 <  4.0
TG (mmol/L) 1.95 1.15 0.29- 1.83
K (mmol/L) 3.63 4.04 3.5- 5.3
Na (mmol/L) 145.5 144.4 137.0- 147.0
HbA1c (%) 6.6 6.0 4.5- 6.1
BNP (pg/ml) 813 168 0- 334
cTnT (ng/L) 18.4 12.1 0- 14
CK-MB (ng/mL) 6.20 5.40 <  2.88
Aldosterone (ng/dL) 17.15 9.8- 27.5
PRA (ng/mL.h) 6.62 0.93- 6.56
ARR (ng/dL: ng/mL.h) 2.59
Plasma norepinephrine (ng/L) 152 174- 357
Plasma epinephrine (ng/L) 76 60- 104
Urinary norepinephrine (μg/24 h) 8.68 16.3-41.5
Urinary epinephrine (μg/24 h) 3.21 7.5-21.9

ALT alanine aminotransferase, ARR aldosterone-to-renin ratio, AST aspartate transaminase, BNP brain natriuretic peptide, BUN blood urea nitrogen, CK-MB creatine kinase-MB, Cre creatinine, cTnT cardiac troponin T, Glu glucose, Hb hemoglobin, HbA1c glycosylated hemoglobin, K potassium, LDL-c low-density lipoprotein cholesterol, Na sodium, Plt platelet, PRA plasma renin activity, TG triglyceride, WBC white blood cell count

Table 2

Results of hormone levels and dexamethasone suppression tests

08:00 ACTH (ng/L) 24 h UFC (ug/24 h) 24:00 PTC (nmol/L) 08:00 PTC (nmol/L) 08:00 PTC the next day (nmol/L)
Before operation Baseline <  1.0 634.8 716.0 858.4
1 mg ODMST 767.0 787.5
After right adrenalectomy Baseline <  1.0 40.8 202.1 223.9
1 mg ODMST 211.6 290.1

ACTH adrenocorticotropic hormone, ODMST overnight dexamethasone suppression test, PTC plasma total cortisol, 24 h UFC 24 h urine free cortisol

For differential diagnosis, aldosterone-to-renin ratio (ARR) was measured after discontinuation of irbesartan and nifedipine XR for at least 2 weeks as they might lead to false-negative result. Plasma and urinary catecholamine concentrations were detected as well. The diagnosis of primary aldosteronism (PA) was excluded since both plasma renin activity (PRA) and aldosterone concentration (PAC) were within normal limits along with an ARR value of 2.59 ng/dL: ng/mL.h. Pheochromocytoma was also ruled out based on laboratory findings (Table 1).

Three adrenal nodules were found with adrenal contrast-enhanced CT. One on the right side was 2.5 cm in diameter, and the other two on the left side with diameters of 2.3 cm and 0.6 cm, respectively (Fig. 1). Magnetic resonance imaging (MRI) of sellar region revealed normal findings. Bone mineral density measured by dual-energy X-ray absorptiometry scans showed that the T score of lumbar spine, femoral neck and the total hip was − 3.0, − 3.2 and − 3.3, respectively, which indicated osteoporosis. In order to locate the functional lesions in this patient, AVS was performed and the concentrations of plasma aldosterone and cortisol were measured from both adrenal veins (AV) and inferior vena cava (IVC). Adrenal venous catheterization was successful, and the hormone levels were shown in Table 3. The adrenal vein to inferior vena cava cortisol (AV: IVC) gradient was 13.57 on the right side and 13.88 on the left side. The left and right AV to IVC gradient of aldosterone were 5.58 and 6.79 respectively. Moreover, the cortisol/aldosterone ratio (CAR) in adrenal veins was 292.52 on the right and 359.29 on the left, along with a left-to-right odds ratio of 1.23 (Table 3). In combination with the results of AVS, which indicated non-lateralization, this patient was diagnosed with CS induced by bilateral adrenal excessive cortisol secretion.Fig. 1

Adrenal computed tomography (CT) of the patient. Adrenal CT showed a right adrenal nodule with a diameter of 2.5 cm, and two left nodules with diameters of 2.3 cm and 0.6 cm, respectively (arrows)

Table 3

Results of adrenal venous sampling

Aldosterone (ng/dL) Cortisol (nmol/L) Cortisol/Aldosterone ratio Lateralization ratio
Left adrenal vein 27.73 9963 359.29 1.23
Right adrenal vein 33.29 9738 292.52
Inferior vena cava 4.97 717.6
AV: IVC ratio (left/right) 5.58/ 6.79 13.88/13.57

AV adrenal vein, IVC inferior vena cava

Treatment and follow-up

The patient was treated with metoprolol succinate, rosuvastatin, insulin, calcium and vitamin D supplements during the investigation. Considering her poor cardiac function, a two-step operation was planned. Laparoscopic right adrenalectomy was performed, followed by left adrenalectomy after a two-month interval. Pathological findings of the removed right adrenal mass indicated a yellow adenoma with 2.5 cm in diameter, surrounded by atrophic adrenal tissue (Fig. 2).Fig. 2

Pathological findings of the resected adrenal glands. Pathological examination of the right (a) and left adrenal gland (b and c) indicated bilateral adrenal adenomas (HE stain, × 200)

Overnight 1 mg DMST was repeated 2 weeks after surgery, which demonstrated no inhibition on the serum cortisol at 8 a.m. on the following day, despite significantly decreased cortisol level post-operation (Table 2). Therefore, it can be inferred that the autonomous cortisol secretion from left adrenal masses was persistent. The left adrenal gland was then removed and two adenomas were confirmed by pathological examination (Fig. 2). The 8 a.m. plasma cortisol after 3 days of bilateral adrenalectomy was 37.30 nmol/L. Hydrocortisone replacement therapy (from 20 mg t.i.d to 20 mg q.d.) was administered after surgery. At 1 year after the operations, the patient lost 4 kg of body weight and the waist circumference reduced to 71 cm. Changes of other laboratory examinations at the last follow-up compared with the first admission were shown in Table 1.

Literature review

An electronic literature search in PubMed was performed to screen the case reports relating to ACTH-independent Cushing’s syndrome caused by bilateral cortisol-secreting adenomas. Searching words included “Cushing’s syndrome” and “bilateral adrenocortical adenoma”. All reference lists from the main reports and relevant reviews were screened manually for additional eligible studies. The results were limited to full-text articles published in English. Extracted data included the first author’s name, year of publication, country, preoperative diagnostic technique, patient characteristics (gender, age at onset and at diagnosis), lesions size, operative method and tumor cut surface.

A total of 231 papers were identified, of which, 15 available reports were included in the review (Fig. 3). The clinical features in these patients were summarized as following: 1) this disorder seemed predominated in females (male: female ratio 1: 14), with an adult onset (the mean age was 39.6 ± 8.6 years; ranged from 24 to 53 years); 2) the size of bilateral adrenal adenomas ranged from 1.0 to 5.0 cm in diameter, the majority of which were solitary in both sides (12 out of 15, 80%); 3) most of the bilateral adrenal lesions were found to occur synchronously, except that three cases occurred at different periods [[6], [7]]; 4) the surrounded adrenal cortex of resected adenomas was atrophic in most cases; 5) although no recurrence was reported postoperatively, long-term outcomes remain unclear with the longest follow-up duration of 123 months [[8]] (Table 4).Fig. 3

Flowchart of study selection for the literature review

Table 4

The available case reports of CS with bilateral adrenal adenomas

Study ID Country Age (years) Gender Lesions size (cm) Preoperative diagnostic technique
Onset Diag. right left
1963 Chappell, AG. NM 43 47 Female 3.0, 1.5 3.0 Left AVS and clinical manifestation
1985 Mimou N. Japan NM 43 Female 2.0 2.5 AVS without correction and Adrenocortical scintigraphy with 75Se-Scintadren
1995 Dinneen SF. America 49 69 Female 3.1 2.1 AVS without correction
1997 Makino, S. Japan 35 45 Female 2.5, 2.0 2.4 Adrenocortical scintigraphy with 131I-adosterol
1997 Tamura, H. Japan 43 48 Female 3.5 2.4 Adrenocortical scintigraphy with 131I-adosterol
2003 Nomura, K. Japan 33 37 Female 1.8 1.6 Adrenocortical scintigraphy with 131I-NP-59
2004 Tung SC. Taiwan 24 33 Female 3.0 3.0 Adrenocortical scintigraphy with 131I-NP-59
2006 Desai, N. America 30 30 Female 2.0 3.0 Iodocholesterol scan
2006 Inoue T. Japan 39 41 Female 2.0 2.4 Adrenocortical scintigraphy
2007 Domino, JP. Singapore NM 35 Female 1.8 2.2 AVS adjusted by aldosterone
2008 Oki, Kl. Japan 35 50 Female 1.1 1.0 AVS adjusted by aldosterone and Adrenocortical scintigraphy with 131I-adosterol
2012 Martins, RG. UK 51 59 Female 2.8 2.6 AVS without correction
2013 Ku, EJ. Korea 45 48 Female 2.8 2.3, 1.7 AVS without correction
2014 Yasuda, A. Japan 53 63 Male 2.4 2.5 AVS without correction and Adrenocortical scintigraphy with 131I-adosterol
2015 Monno, S. Japan 35 39 Female 2.4 3.1 Adrenocortical scintigraphy with 131I-NP-59
Study ID Operation Cut surface Functional side
right left
1963 Chappell, AG. Left, right total adrenalectomy (2 months later) Yellow NM NM
1985 Mimou N. Bilateral total adrenalectomy Dark brown Brownish-yellow Bilateral adenomas
1995 Dinneen SF. Bilateral total adrenalectomy NM NM Bilateral adenomas
1997 Makino, S. Bilateral total adrenalectomy Yellow, Black Yellow Left adenoma, the black right adenoma
1997 Tamura, H. Bilateral total adrenalectomy Brown NM Bilateral adenomas
2003 Nomura, K. Bilateral subtotal adrenalectomy Black Black Bilateral adenomas
2004 Tung SC. Right, left total adrenalectomy (9 years later) Yellow Yellow Bilateral adenomas
2006 Desai, N. Bilateral total adrenalectomy Yellow/ tan Yellow/ tan Bilateral adenomas
2006 Inoue T. Bilateral partial adrenalectomy Yellowish-brown Yellowish-brown Bilateral adenomas
2007 Domino, JP. Right total adrenalectomy, left partial adrenalectomy NM NM Bilateral adenomas
2008 Oki, Kl. Left partial adrenalectomy, right total adrenalectomy Golden yellow NM Bilateral adenomas
2012 Martins, RG. Bilateral total adrenalectomy NM NM Bilateral adenomas
2013 Ku, EJ. Bilateral total adrenalectomy Brown Light brown Bilateral adenomas
2014 Yasuda, A. Left total adrenalectomy, right partial adrenalectomy NM NM Bilateral adenomas
2015 Monno, S. Left, right total adrenalectomy (3 months later) Yellow Golden Bilateral adenomas

AVS adrenal venous sampling, CS Cushing’s syndrome, NM not mentioned, 75Se-Scintadren 6-methyl-75Se-selenomethyl-19-norcholeste-5(10)-en-3ß-ol, 131I-NP-59131I-6β-iodomethyl-19-norcholesterol

All preoperative diagnoses were established based on endocrinological studies and imaging findings, while the methods used to determine the functional lesions were different. Nine patients underwent adrenocortical scintigraphy with different radio-imaging agents, all of which revealed bilateral adrenal uptake. AVS was performed in eight cases to evaluate the hypersecretion of cortisol, and only two of them applied cortisol gradient adjusted by plasma aldosterone [[9], [10]]. All patients underwent surgical resection of adenomas, including ten bilateral total adrenalectomy [[6], [11][19]], three unilateral partial adrenalectomy with contralateral total adrenalectomy [[9], [10], [20]], one bilateral partial adrenalectomy [[21]] and one bilateral subtotal adrenalectomy [[22]]. All patients received glucocorticoid replacement therapy postoperatively. It is noteworthy that glucocorticoid therapy was reported to be withdrawn during follow-up in patients who underwent bilateral subtotal adrenalectomy or partial adrenalectomy [[21][23]].

Discussion and conclusion

ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adenomas has been rarely reported in the literature [[6], [8][24]]. This disorder should be differentiated from PPNAD, AIMAH and unilateral functional adenoma with contralateral non-functional lesion for the determination of therapeutic regimen. PPNAD is characterized by multiple small pigmented nodules of hyperplastic adrenocortical cells and cortical atrophy with an early age of onset [[25]]. AIMAH, in which the bilateral enlarged adrenal glands with numerous nodules larger than 1 cm in diameter lead to an irregular contour on CT or MRI, is associated with aberrant expression of hormone receptors and can be treated by appropriate antagonist [[26], [27]]. The definite diagnosis of AIMAH or PPNAD depends on histo-pathology. Although the clinical characters of some similar cases were identified by several previous studies, precise diagnosis and treatment of patients with bilateral ACTH-independent adrenal adenomas remain challenging [[8], [23], [24]].

The diagnostic value of AVS and 131I-6β-iodomethyl-19-norcholesterol (131I-NP-59) scintigraphy for defining the hormone-secreting status in adrenocortical diseases was well established [[28][30]]. NP-59, which was clinically available in 1975 and most frequently used, can be accumulated by functioning adrenal cortical tissues as radiolabeled cholesterol analog [[31]]. The uptake of NP-59 would reflect the anatomic localization and functional characterization of adrenal masses accordingly. Since the 131I-NP-59 scintigraphy is unavailable in most hospitals in China and many other countries, an alternative technique is needed for the diagnosis.

AVS has been recommended over the past 10 years by international guidelines to differentiate unilateral from bilateral primary aldosteronism through cortisol-corrected aldosterone ratio [[30], [32], [33]]. During AVS, blood was collected from bilateral AV and IVC or peripheral vein (PV) to measure aldosterone and cortisol levels, and the comparison of AV and IVC cortisol concentration was further used to assess whether successful cannulation was achieved in PA. In this case, we used the AV: IVC aldosterone ratio to assess the successfulness of catheter insertion since the aldosterone concentration could remain stable during the sampling. There were some researches in which adrenaline concentration was measured to evaluate catheterization accuracy, however, catheterization process itself might lead to stress-induced fluctuation of adrenaline and further result in misjudgment [[17], [34]]. Even though there is still no general agreement on the definition of catheterization success in AVS, aldosterone concentration instead of adrenaline could be a robust assay for this purpose, after the aldosterone overproduction being excluded.

We used AV: IVC cortisol ratio in both side and left-to-right CAR gradient to differentiate unilateral from bilateral cortisol overproduction. Young et al. [[8]] suggested that if the cortisol gradient of AV to PV or IVC was greater than 6.5, cortisol-secreting adenoma should be considered. Although the accuracy and applicability remain to be proved due to the lack of research in this area, we can at least assume that a larger ratio represents a greater likelihood of spontaneous cortisol secretion. The authors also proposed cutoff values of high- to low-side AV cortisol gradient ratio to determine the lateralization of cortisol hypersecretion, and suggested that predominant cortisol secretion was considered if the cortisol lateralization ratio was ≥2.3 [[8]]. However, unadjusted cortisol lateralization ratio might confound the interpretation of AVS results because of the cortisol concentration was 1.8 times higher in the right AV than in the left side, which was the result of dilution effect [[35]]. Since PA was ruled out in this patient, the correction was considered to be achieved through aldosterone in this setting. It should be noted, however, that AVS cannot be used to differentiate the functional status of each mass in the left adrenal gland.

AVS is generally safe, with a very low risk of adverse events. The rate of adrenal venous rupture, one of the main complications, was reported as 0.61% in a recent international multicenter study [[36]]. Adrenal vein thrombosis, infarction and perforation, and subsequent periadrenal hemorrhage and hematoma have been also reported in the literature [[37]]. In consideration of the risk of failure and complications, experienced radiologists were suggested for this invasive procedure. In this case, no adverse event was observed throughout the duration of treatment and follow-up.

The optimal treatment for patients with bilateral cortisol-secreting adenomas remains uncertain [[27], [38]]. Two-step bilateral adrenalectomy was performed on our patient and resulted in remarkable remission of hypercortisolism, and further confirmed the cortisol-secreting feature of each adrenal mass. Even though lifelong steroid supplementation was required, the quality of her life improved considerably. However, lifelong follow-up of the patient is required regarding to the unclear long-term outcome of bilateral adrenalectomy in this disease [[39], [40]]. Recently, partial adrenalectomy (removal of the adenomas only) was performed in some similar cases, in which functional recovery of hypothalamic-pituitary-adrenal axis could be achieved after surgery, while further studies for prognosis are still warranted [[9], [20], [21], [23]].

In summary, we reported a Chinese female patient with ACTH-independent CS caused by bilateral cortisol-secreting adenomas. She was diagnosed through aldosterone-adjusted AVS and successfully treated with bilateral adrenalectomy. It confirmed that selective AVS with aldosterone-corrected cortisol ratio could be a useful technique to evaluate the cortisol-secreting function of each adrenal mass and further guide therapeutic decision-making. Owing to the existing dispute over the interpretation of the AVS results, the definite cut-off values for lateralization of cortisol hypersecretion requires further confirmation.

Acknowledgements

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

References

  1. J Newell-PriceX BertagnaAB GrossmanLK NiemanCushing's syndromeLancet200636795221605161710.1016/S0140-6736(06)68699-616698415
  2. D GraversenP VestergaardK StochholmCH GravholtJO JorgensenMortality in Cushing's syndrome: a systematic review and meta-analysisEur J Intern Med201223327828210.1016/j.ejim.2011.10.01322385888
  3. A LacroixI BourdeauBilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical diseaseEndocrinol Metab Clin N Am200534244145810.1016/j.ecl.2005.01.004
  4. JL DoppmanThe dilemma of bilateral adrenocortical nodularity in Conn's and Cushing's syndromesRadiol Clin N Am1993315103910508362054
  5. A MaghrabiA YaqubKL DenningN BenhamedS FaizT SaleemChallenges in the diagnostic work-up and management of patients with subclinical Cushing's syndrome and bilateral adrenal massesEndocr Pract201319351552110.4158/EP12277.RA23425643
  6. SC TungPW WangTL HuangWC LeeWJ ChenBilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomyJ Endocrinol Investig200427437537910.1007/BF0335106615233560
  7. T ImaiH FunahashiY TanakaJ TobinagaM WadaT Morita-MatsuyamaAdrenalectomy for treatment of Cushing syndrome: results in 122 patients and long-term follow-up studiesWorld J Surg199620778178610.1007/s0026899001198678951
  8. WF Young JrH du PlessisGB ThompsonCS GrantDR FarleyML RichardsThe clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal massesWorld J Surg200832585686210.1007/s00268-007-9332-818074172
  9. JP DominoSB ChionhD LomantoAN KataraA RauffWK CheahLaparoscopic partial adrenalectomy for bilateral cortisol-secreting adenomasAsian J Surg200730215415710.1016/S1015-9584(09)60152-417475590
  10. K OkiK YamaneY SakashitaN KameiH WatanabeN ToyotaPrimary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomasClin Exp Nephrol200812538238710.1007/s10157-008-0064-318543063
  11. AG ChappellCushing's syndrome due to bilateral adrenal adenomataProc R Soc Med196356316516619994207
  12. N MimouS SakatoH NakabayashiZ SaitoR TakedaF MatsubaraCushing's syndrome associated with bilateral adrenal adenomasActa Endocrinol198510822452543969816
  13. SF DinneenJA CarneyPC CarpenterCS GrantWF Young JrActh-independent Cushing's syndrome: bilateral cortisol-producing adrenal adenomasEndocr Pract199512778110.4158/EP.1.2.7715251598
  14. S MakinoH ChikazawaA YorimitsuT SuehiroK HashimotoY OhashiA rare case of Cushing's syndrome due to bilateral adrenocortical adenomasEndocr J199744453354010.1507/endocrj.44.5339447286
  15. H TamuraH SugiharaS MinamiN EmotoT ShibasakiY ShutoCushing's syndrome due to bilateral adrenocortical adenomas with different pathological featuresIntern Med1997361180480910.2169/internalmedicine.36.8049392354
  16. N DesaiA KapoorBK SinghJ LiuBilateral adrenal adenomas and persistent leukocytosis: a unique case of Cushing's syndromeAm J Med20061193e3e510.1016/j.amjmed.2005.07.02216490458
  17. RG MartinsR AgrawalDM BerneyR ReznekM MatsonAB GrossmanDifferential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous samplingEndocr Pract2012186e153e15710.4158/EP12136.CR22982799
  18. EJ KuAR HongYA KimJH BaeMS ChangSW KimAdrenocorticotropic hormone-independent Cushing syndrome with bilateral cortisol-secreting adenomasEndocrinol Metab (Seoul)201328213313710.3803/EnM.2013.28.2.13324396667
  19. S MonnoT TachikawaT MaekawaH SasanoA case of Cushing's syndrome due to bilateral cortisol-secreting adenomas with unilateral DHEAS oversecretionEndocr J201562328328810.1507/endocrj.EJ14-055225736067
  20. A YasudaT SekiK ItoA TakagiD WatanabeN NakamuraA rare case of Cushing's syndrome due to bilateral adrenocortical adenomasTokai J Exp Clin Med201439415816525504201
  21. T InoueK IshiguroT SudaN ItoY SuzukiY TaniguchiLaparoscopic bilateral partial adrenalectomy for adrenocortical adenomas causing Cushing's syndrome: report of a caseSurg Today2006361949710.1007/s00595-005-3102-816378204
  22. K NomuraH SaitoM AibaM IiharaT ObaraK TakanoCushing's syndrome due to bilateral adrenocortical adenomas with unique histological featuresEndocr J200350215516210.1507/endocrj.50.15512803235
  23. Z LiY ZhuC KongL YinZ GaoW ZhaoCorticotropin-independent Cushing's syndrome in patients with bilateral adrenal massesUrology201177241742110.1016/j.urology.2010.09.04521167562
  24. M AibaM KawakamiY ItoY FujimotoT SudaH DemuraBilateral adrenocortical adenomas causing Cushing's syndrome. Report of two cases with enzyme histochemical and ultrastructural studies and a review of the literatureArch Pathol Lab Med199211621461501733407
  25. A HorvathC StratakisPrimary pigmented nodular adrenocortical disease and Cushing's syndromeArq Bras Endocrinol Metabol20075181238124410.1590/S0004-2730200700080000918209861
  26. NM AlbigerF CeccatoM ZilioM BarbotG OcchiS RizzatiAn analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experienceClin Endocrinol201582680881510.1111/cen.12763
  27. LK NiemanBM BillerJW FindlingMH MuradJ Newell-PriceMO SavageTreatment of Cushing's syndrome: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab201510082807283110.1210/jc.2015-181826222757
  28. F LumachiP ZucchettaMC MarzolaF BuiG CasarrubeaF AngeliniUsefulness of CT scan, MRI and radiocholesterol scintigraphy for adrenal imaging in Cushing's syndromeNucl Med Commun200223546947310.1097/00006231-200205000-0000711973488
  29. CE Builes-MontanoCA Villa-FrancoA Roman-GonzalezA Velez-HoyosS Echeverri-IsazaAdrenal venous sampling in a patient with adrenal Cushing syndromeColomb Med (Cali)2015462848726309345
  30. JW FunderRM CareyF ManteroMH MuradM ReinckeH ShibataThe management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab201610151889191610.1210/jc.2015-406126934393
  31. SD SarkarH BeierwaltesRD IceGP BasmadjianKR HetzelWP KennedyA new and superior adrenal scanning agent, NP-59J Nucl Med19751611103810421185265
  32. T NishikawaM OmuraF SatohH ShibataK TakahashiN TamuraGuidelines for the diagnosis and treatment of primary aldosteronism--the Japan endocrine society 2009Endocr J201158971172110.1507/endocrj.EJ11-013321828936
  33. JW FunderRM CareyC FardellaCE Gomez-SanchezF ManteroM StowasserCase detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab20089393266328110.1210/jc.2008-010418552288
  34. YW GuoCM HwuJG WonCH ChuLY LinA case of adrenal Cushing's syndrome with bilateral adrenal massesEndocrinol Diabetes Metab Case Rep20162016150118
  35. WF YoungAW StansonGB ThompsonCS GrantDR FarleyJA van HeerdenRole for adrenal venous sampling in primary aldosteronismSurgery200413661227123510.1016/j.surg.2004.06.05115657580
  36. GP RossiM BarisaB AllolioRJ AuchusL AmarD CohenThe Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronismJ Clin Endocrinol Metab20129751606161410.1210/jc.2011-283022399502
  37. N DauntAdrenal vein sampling: how to make it quick, easy, and successfulRadiographics200525Suppl 1S143S15810.1148/rg.25si05551416227488
  38. M IiharaR SuzukiA KawamataY OmiH KodamaY IgariAdrenal-preserving laparoscopic surgery in selected patients with bilateral adrenal tumorsSurgery200313461066107210.1016/j.surg.2003.07.02714668742
  39. ZH LiXY YuYY ZhuYX ZhangCZ KongSteroid replacement therapy following adrenalectomy in patients with Cushing syndromeJ China Med Uni20103906476477
  40. K RitzelF BeuschleinA MickischA OsswaldHJ SchneiderJ SchopohlClinical review: outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic reviewJ Clin Endocrinol Metab201398103939394810.1210/jc.2013-147023956347
The underlying source XML for this text is taken from https://www.ebi.ac.uk/europepmc/webservices/rest/PMC5913873/fullTextXML. The license for the article is Creative Commons Attribution 4.0 International. The main subject has been identified as hyperaldosteronism.